EMBRYO QUALITY PREDICTIVE MODELS BASED ON CUMULUS CELLS GENE EXPRESSION
Devjak R, Burnik Papler T, Verdenik I, Fon Tacer K, Vrtačnik Bokal E
*Corresponding Author: Rok Devjak, M.D., Ph.D., Division of Medical Oncology, Institute of Oncology, Zaloška 2, 1000 Ljubljana, Slovenia. Tel: +386-1-5879-282; Fax: +386-1-5879-303. E-mail: rdevjak@onko-i.si
page: 5

DISCUSSION

In the present study, we analyzed CC expression of AMHR2, LIF, SERPINE2, VEGFC and FSHR from oocytes that developed into either high quality or low quality embryos. In our previous study [10], selected genes were shown to be well differentiated between immature MI and mature MII oocytes, according to CC expression. In this study, we use them as potential biomarkers of embryo quality. Only AMHR2 and LIF were shown to be significant and were used in our prediction models. In either the binary logistic model or decision tree model, the predictive power was the best when both genes were used simultaneously. In recent years, many studies have been performed to analyze CC gene expression in association with various endpoints: oocyte maturity, embryo development and pregnancy [8,9,16,18]. Since CC is an easily accessible material that is normally discarded during the IVF cycle, it represents a good biological material for research and hopefully, someday, also for diagnostic purposes. In previous studies on CC gene expression, many genes were shown to be differentially expressed between observed groups of oocytes, but not many were tested for predictive power [19]. As a main characteristic of a good diagnostic test is high predictive power, the AUC value (defined by high sensitivity and specificity), only genes which would yield a good predictive power, whether alone or in combination with other genes in repeated trials, would be suitable for potential CC gene expression diagnostic testing. The AMH works through its receptor AMHR2, being the highest in the preantral follicle for their recruitment, and during follicle maturation it gradually diminishes [20-22]. It has also been proved that AMHR2 CC level decreases with the level of oocyte maturity and in the same manner is expressed by AMH in CC [10,23]. In this study, the CC expression of AMHR2 was significantly negatively correlated with embryo quality. This again indicates that oocyte maturity is a prerequisite for high quality embryo development. In this study two models were constructed with AMHR2 for high quality embryo prediction, and both showed similar predictive power. In comparison to models based on LIF CC expression, AMHR2- based models show better predictive power, which can be well-explained by higher CC expression differences between high and low quality embryos in AMHR2 compared to LIF. The connection of LIF with reproduction was shown in the study where LIF was abundantly expressed in the uterine endometrial glands on day 4 of pregnancy [24]. Namely, the p53 protein regulates the LIF expression and sufficient LIF levels are crucial for embryo implantation [25,26]. In addition, the role of LIF in reproduction is not only in implantation but also in CC expansion. In the study of LIF function in in vitro maturated human and mice cumulus-oophorus complex, it was proven that LIF supple-mentation induced cumulus expansion in both settings [17]. LIF also plays a role in blastocyst formation, where the group of bovine cumulus-oocyte complexes that were incubated with LIF yielded higher blastocyst development compared to the control group without LIF [27]. In our study LIF CC expression showed significance between CC of high quality and low quality embryos only when a subgroup with high AMHR2 CC expression was observed. Therefore, using LIF alone in the model results in lower predictive power than AMHR2 but when used together, LIF improves the prediction value of AMHR2. Logistic regression represents the gold standard for constructing prediction models in biomedical studies. As its statistic is based on logistic regression, for each attribute the model computes a coefficient and combines them into one prediction variable. These are used for the receiver-operator curve (ROC) and computing AUC values, but as such, a prediction variable has no informational value for to user (i.e. clinician). Predictive data mining has become one of the essential tools for the researcher in medicine [28]. One of these techniques is also the decision tree, where a decision is made in each node, according to the value and predictive power of the variable. At the end (leaves) the probability of an event is given. Decision trees are usually represented with diagrams but can also be with “if sentences.” Diagrams make the decision tree model easy to interpret, therefore, a model with more informational value for the user. In our study, both types of models, binary logistic and decision trees, resulted in similar AUC values, indicating that the type of the models used does not improve the predictive power. Analyzing the decision tree diagram of the model with AMHR2 and LIF leads to the conclusions that first, when both AMHR2 and LIF are low, there is a high possibility of the development of high quality embryos; second, when AMHR2 is high and LIF is low, there is a high possibility of developing low quality embryos, and third, all other combinations of AMHR2 and LIF expression result in the equal possibility of developing of high quality or low quality embryos. An equal chance of developing a high quality or low quality embryo upon AMHR2 and LIF expression actually means that the model is unable to predict the outcome, and this group contained exactly half of all observed embryos. Additional biomarkers would probably improve prediction for this group of embryos, or some other factors exist which we currently did not take into consideration, e.g. the quality of spermatozoa. A logistic regression of CC expression was also used for constructing predictive models in the study by McKenzie et al. [29]. In their study, the expression values of hyaluronic acid synthase 2 (HAS2), cyclooxygenase 2 (PTGS2) and gremlin (GREM1) were used for constructing regression models for oocyte maturity, oocyte fertilization and embryo quality. Regression models for embryo quality yielded an AUC of 0.76, 0.76 and 0.81 for HAS2, PTGS2 and GREM1, respectively. Combining PTGS2 and GREM1 only slightly improved the predictive power (AUC 0.82 vs. 0.81). Besides PTGS2, the study by Wathlet et al. [30] also used six other genes and tested them for predictive power of cleavage stage embryo prediction and pregnancy prediction. Among the tested genes, the best cleavage stage embryo prediction relied on TRPM7 and ITPKA, but the AUC value was not calculated. Another prognostic model for pregnancy was published by Iager et al. [31], where 12 genes previously recognized by microarray, were tested by qPCR for their predictive power. They used a “signal to noise” ratio to assess the predictive value of a gene using weighted voting. The AUC value for pregnancy prediction was 0.76 ± 0.08.



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006